Accurate Diagnosis, Appropriate Treatment Selection

CE / CME

eCase: Accurate Diagnosis Leads to Appropriate Treatment Selection in Patients With Bipolar Depression

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Social Workers: 1.00 ASWB ACE CE Credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Psychologists: 1.00 APA CE Credit

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit 

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: September 30, 2022

Expiration: September 29, 2023

Leslie Citrome
Leslie Citrome, MD, MPH

Activity

Progress
1
Course Completed

This eCase by Leslie Citrome, MD, MPH, explores how to accurate diagnose and individualize treatment for a patient with bipolar depression.

To receive CME credit for this activity, please review the entire content of the activity. After reviewing the module, click the “Claim Credit” button on your screen to complete the posttest and evaluation.

Clinical Care Options plans to measure the educational impact of this activity, and some questions in this activity will be asked twice, once prior to the activity and then once again at the end. Your responses will be aggregated for analysis, but your specific responses will not be shared.

Lumateperone, cariprazine, and lurasidone are distinguished from quetiapine and olanzapine/fluoxetine combination principally by?
Which of the following is true regarding FDA-approved treatments for bipolar depression?
Which of the following is true regarding major depressive disorder (MDD) and bipolar depression?